Poster Exhibitors
Engineering & Physical Sciences Track
Gschools Inc. is an internationally focused brokerage company
that has developed an innovative technical methodology designed to integrate
global opportunities for its members. Its members include students, job
seekers, international universities and colleges, private institutions,
government and corporate stakeholders. www. gschools.ca
Gschools Inc. is developing an international research and development brokerage
agency to create dynamic collaborations to improve productivity growth.
Project T2 will be an excellent opportunity to learn more about the company
and membership benefits for your educational institution or corporation.
Rutgers University - SPIDER System
SPIDER is a video based system developed under contracts from DARPA and
TSWG of the Department of Homeland Security. Spider provides a number of
features in the visualization of several and possibly many video streams.
One feature provides for recognition of user specified objects with specific
trajectories. For example, in surveillance applications video streams could
be search for the event of a person walking with a package and leaving the
package and walking away. In home entertainment videos could be searched
for images where grandma is recognized and she is dancing. Spider also allows
the formation and navigation of 3D video game models of the video of the
video streams in real time.
UC Irvine - Intelligent Imaging Solutions
Our patented Visual Neural Classifier transforms a database of medical images into a "relational map" of labeled dots, one dot for each image. The dots are arranged to cluster in classes consisting of images that are medically and visually similar to each other. The relational map is the core of a graphical engine for searching a large database of pathology-proven images for images that are similar to a query image. In preliminary tests, our map helped radiologists reduce the number of false positives among query images by about 40 percent, with no loss of sensitivity.
The virtual bone technology constructs realistic models of human bone based
on bone's characteristics as a biological composite material with a hierarchical
structure. The technology incorporates properties of bone microstructure
established through a variety of investigative methods, including sophisticated
microscopy techniques, micro-dissection to isolate bone micro-structures,
and their micro-mechanical testing. The technology enables assessment of
bone quality and prediction of bone fracture in patients. Its applications
include the planning of prosthetic and other orthopedic and dental interventions
on bone, as well as the assessment and design of pharmacologic treatments
for conditions such as osteoporosis.
UCSB - Inlustra Technologies, LLC
Inlustra Technologies is a spin-off company from UC Santa Barbara's renowned
gallium nitride crystal growth research program, headed by professors Shuji
Nakamura, James Speck, and Steven DenBaars. Inlustra will manufacture high-quality
gallium nitride substrates enabling production of low cost blue DVD lasers
and high-brightness blue, green, and white light emitting diodes. We will
use our UCSB lab-proven crystal growth technology to produce next-generation
substrates that will significantly increase our customers' device efficiencies
and manufacturing yields.
Total Privacy Using One-Round Zero-Knowledge Proof
"Sir, to verify your identity, what's your mother maiden name, SSN, and …"
Why should we compromise our privacy to verify identity? With Total Privacy
you don't. You can prove the knowledge of the secret but without revealing
it. Total Privacy uses our one-round zero-knowledge proofs technique. The
"one-round" improvement reduces time complexity and network usage,
making this innovation an attractive solution for many cryptographic applications,
such as access control and privacy protection.
Contour Crafting is a computer-automated construction technology, invented and developed at USC to deliver rapid production, ease of use, significant reduction of waste, and other substantial cost savings. Not only will CC have a significant impact on the point of delivery, but the whole support structure will be similarly affected by the technology. CC has been designed to deliver improved qualify of life, superior safety, and beneficial environmental impact.
Trusted Email (TE) and its Full Address Verification Service (FAVS) prevent fraudulent credit card transactions for intangible merchandise, where no shipment involved. FAVS is superior to existing systems that use billing address or other codes for credit card verification. TE is easier to implement than credit card secret pin or surrogate card numbers. This integrated solution saves time and money for merchants and consumers; and reduces and streamlines dispute management for credit card issuers.
ZDimension's Technology allows multiple people to interact with hologram like 3D images using a stylus-like light source and simple hand movements. The technology allows a range of users to utilize existing no-glasses 3D displays with the proprietary integration software. The technology is patent protected. The patent also includes the use of 3D spatial audio and allows ZDimension's technology to create totally immersive solutions for air traffic control, network security and science education.
Life Sciences Track
California Pacific Medical Center Research Institute - Colon Cancer Diagnostic Kit
A colon cancer diagnostic kit consists of biomarkers for the early detection of colorectal cancer. The kit will provide a simple, non invasive and inexpensive alternative for colonoscopy. The kit can be used routinely by a physician in an office-setting to obtain a simple rectal smear test and to screen for colon cancer. The biomarkers panel will allow identifying individuals who are most likely to have colonic polyps, and therefore in most need of colonoscopy. In addition, the panel will identify individuals who are most likely to develop colon cancer in the future.
California Pacific Medical Center Research Institute - Novel and Improved Anti-Cancer Drugs
Novel anti-cancer drugs that are up to 1,000 times more effective in killing human cancer cells than the currently available anti-cancer drugs. These new drugs have been proven to be 500 times less toxic to normal cells than currently available chemotherapeutic agents. Among these drugs, some exhibit highly specific killing effects on human prostate and breast cancer cells. The preparation of these novel drugs is straightforward, cheap and fast.
California Pacific Medical Center Research Institute - Detection of Invasive & Metastatic Cancers
Metastasis is the final and fatal step during cancer progression. There are only few therapeutic interventions available and those are highly toxic and not highly effective. Identifying molecular targets that are functionally involved in the metastasis conversion of cancer cells are urgently needed. Id-1 protein has been identified as a target in metastasis conversation and as a marker for aggressive cancers of various tissue origins. Incorporation of Id-1 in cancer pathological screening will be of great value for diagnostic and prognostic purposes, as well as for aiding oncologists to determine personalized treatment strategies.
The Beckman Research Institute at the City of Hope has developed new approaches to the design of siRNAs that can result in increased potency when compared to "standard 21mer" molecules. The increased potency of the siRNA designs arises from improved interaction with the Dicer complex.
UC Irvine - Intellego Corporation
Intellego is an easy to use, high throughput, high content, cell sorting technology. It can enable life science researchers to analyze many thousands of adherent cells at high speed and high content without the need for a flow cytometer. Furthermore, the technology allows one to rapidly select one in a million cells without damaging them, so that they can be safely removed for further analysis and cloning. The technology is revolutionary and will enable dramatic increases in productivity among cell biologists and microbiologists, as well as fundamentally new techniques in research. The technology can be delivered at low cost for individual researchers to use (e.g., thought leaders at Universities), but can be readily scaled up to large production units for pharma. Intellego works for cells (including stem cells), colonies, tissues, organisms, embryos, DNA, RNA, proteins and antibodies. The technology is based on patent pending technology from UC Irvine.
UC Irvine - Mark Metzke
Our group focuses on the design of new and improved material systems derived
from naturally abundant building blocks (carbohydrates and peptides). Using
these starting materials, we have synthesized two novel classes of biomaterials:
carbohydrate-derived side chain polyethers, and peptide-carbohydrate copolymers.
These materials possess: i) rich functionality, ideal for further structural
fine-tuning, ii) inherent biocompatibility, being derived from biotic starting
materials, iii) biodegradability, linked with enzymatically cleavable bonds,
and iv) synthetic scalability because of design simplicity.
Through the use of proprietary animal models for both diabetic retinopathy and exudative aging-related macular degeneration, SCLERA LLC can assess both novel therapeutic agents and long-term ophthalmic implantable devices for ameliorating these progressive blinding diseases where effective cures currently do not exist. Existing clinical instrumentation can be utilized easily on these practical models to follow drug effects. Moreover, movement of stem cells and their involvement in these ocular diseases and in cancer biology may be imaged diagnostically.
The purpose of this invention is to establish the theoretical concept and applicable methodology for real-time 3-dimentional mapping of endomyocardial monophasic action potential (MAP). A newly designed "Lantern Catheter" will be used for transpercutaneous catheterization followed by 3 dimensionally mapping the endomyocardial MAP. At least 36 points of MAP will be recorded simultaneously and the data will analyzed by standard EP analysis system.
UCLA - Luyi Sen
The invention is in the field of methodologies to facilitate the ex vivo gene, protein or drug delivery in large quantity to various types of isolated cells or cell clusters, such as islets, or various of tissues using ultra low strength electroporation.
UCLA - Luyi Sen
The purpose of this invention is to establish the theoretical concept and applicable methodology for facility of gene, protein or drug therapy targeting in organ and tissue of large animal and human ex vivo and in vivo for using new electroporation strategies. A newly designed 4 Gene Delivery Systems will be used for transferring any therapeutic gene, protein or drugs to the various organs, such as heart, lung, liver, kidney, etc., ex vivo and in vivo, and vessels ex vivo and in vivo.
New Clinical Cancer Test: PINCH
PINCH is a signaling protein that is upregulated in cancer stroma. PINCH
is a significant independent predictor of reduced survival in colorectal
cancer and of nodal metastases in oral squamous cell carcinoma. PINCH may
be a broadly useful indicator of cancer invasive and metastatic potential.
The test is performed by immunohistochemistry and is being adapted to qPCR.
PINCH may be useful in assessing the need for adjuvant chemotherapy and
may identify cancers with metastatic potential.
Use of Stem Cells and Protein Therapeutics in OncologyHematology
Development of Two-Protein Therapeutics as Hematological Adjuvant Cancer Therapies:
" Hemerec-1 and Hemerec-2 are competitive with Neulasta (G-CSF); proof of principle in tumor-bearing animal model.
" Development of a Device containing Stem Cells for Hematopoietic Rescue which may obviate the need for a cellular transplant; proof of principle in animal model.
Mining Adult Tissue for Pluripotent Stem Cells
Development of Proprietary Stem Cell Markers known to be expressed in human
adult tissue. These Markers are currently being used to generate novel adult
human stem cell populations for use in regenerative medicine. Proof of principle
for hematopoiesis, Multiple Sclerosis and hearing loss are now being tested
in animal models.
Rutgers University - Suzie Chen
Prof. Suzie Chen has created a new approach as well as excellent research
tools for Melanoma Research. A novel mouse model, to be used in the in-vivo
screening and appropriate cell lines for high throughput screening, are
part of this invention.